EAU guidelines on renal cell carcinoma: 2014 update
- PMID: 25616710
- DOI: 10.1016/j.eururo.2015.01.005
EAU guidelines on renal cell carcinoma: 2014 update
Abstract
Context: The European Association of Urology Guideline Panel for Renal Cell Carcinoma (RCC) has prepared evidence-based guidelines and recommendations for RCC management.
Objectives: To provide an update of the 2010 RCC guideline based on a standardised methodology that is robust, transparent, reproducible, and reliable.
Evidence acquisition: For the 2014 update, the panel prioritised the following topics: percutaneous biopsy of renal masses, treatment of localised RCC (including surgical and nonsurgical management), lymph node dissection, management of venous thrombus, systemic therapy, and local treatment of metastases, for which evidence synthesis was undertaken based on systematic reviews adhering to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Relevant databases (Medline, Cochrane Library, trial registries, conference proceedings) were searched (January 2000 to November 2013) including randomised controlled trials (RCTs) and retrospective or controlled studies with a comparator arm. Risk of bias (RoB) assessment and qualitative and quantitative synthesis of the evidence were performed. The remaining sections of the document were updated following a structured literature assessment.
Evidence synthesis: All chapters of the RCC guideline were updated. For the various systematic reviews, the search identified a total of 10,862 articles. A total of 151 studies reporting on 78,792 patients were eligible for inclusion; where applicable, data from RCTs were included and meta-analyses were performed. For RCTs, there was low RoB across studies; however, clinical and methodological heterogeneity prevented data pooling for most studies. The majority of studies included were retrospective with matched or unmatched cohorts based on single or multi-institutional data or national registries. The exception was for systemic treatment of metastatic RCC, in which several RCTs have been performed, resulting in recommendations based on higher levels of evidence.
Conclusions: The 2014 guideline has been updated by a multidisciplinary panel using the highest methodological standards, and provides the best and most reliable contemporary evidence base for RCC management.
Patient summary: The European Association of Urology Guideline Panel for Renal Cell Carcinoma has thoroughly evaluated available research data on kidney cancer to establish international standards for the care of kidney cancer patients.
Keywords: Guideline; Meta-analysis; Renal cell carcinoma; Systematic review.
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. Eur Urol. 2022. PMID: 35346519
-
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.Eur Urol Oncol. 2020 Aug;3(4):433-452. doi: 10.1016/j.euo.2020.02.001. Epub 2020 Mar 31. Eur Urol Oncol. 2020. PMID: 32245655
-
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23. Eur Urol. 2019. PMID: 30803729
-
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.Eur Urol. 2015 Jan;67(1):100-110. doi: 10.1016/j.eururo.2014.04.006. Epub 2014 May 1. Eur Urol. 2015. PMID: 24841777 Review.
-
Systematic review of oncological outcomes following surgical management of localised renal cancer.Eur Urol. 2012 May;61(5):972-93. doi: 10.1016/j.eururo.2012.02.039. Epub 2012 Feb 25. Eur Urol. 2012. PMID: 22405593 Review.
Cited by
-
The effect of 11th rib excision on perioperative outcomes in patients undergoing partial nephrectomy for upper pole renal tumors.Int Urol Nephrol. 2024 May 24. doi: 10.1007/s11255-024-04087-5. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38789871
-
Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.Eur J Med Res. 2024 May 21;29(1):292. doi: 10.1186/s40001-024-01883-8. Eur J Med Res. 2024. PMID: 38773560 Free PMC article.
-
Bilateral Renal Cell Carcinoma in the Horseshoe Kidney With Metastasis in Gallbladder, Pancreas and Duodenum: A Report of a Rare Case and Literature Review.Cureus. 2024 Apr 16;16(4):e58363. doi: 10.7759/cureus.58363. eCollection 2024 Apr. Cureus. 2024. PMID: 38756314 Free PMC article.
-
Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study.Front Surg. 2024 Apr 29;11:1370702. doi: 10.3389/fsurg.2024.1370702. eCollection 2024. Front Surg. 2024. PMID: 38742149 Free PMC article.
-
Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinoma.Cancer Cell Int. 2024 May 10;24(1):164. doi: 10.1186/s12935-024-03346-w. Cancer Cell Int. 2024. PMID: 38730293 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical